STOCKS NEWS US-Chemspec ADRs rally in trading debut

Stocks on the move [HOT-RTRS]

Real-time Equity news [U][E] [RESF/US]

For U.S. stock market report double-click [.N]
1103 ET 24June2009-Chemspec ADRs rally in trading debut
------------------------------------------------------------------------------

U.S.-listed shares of Chemspec International (CPC.N) rallied in their
trading debut on Wednesday, after the company's initial public offering was
priced at $9 per American Depositary Receipt, the top of an expected range.

For details, see [ID:nN24418135]

Shares gained 6.9 percent to $9.63.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
1058 ET 24June2009-MGM jumps after "going concern" removal
------------------------------------------------------------------------------

MGM Mirage (MGM.N) shares rose on Wednesday after the company said late
Tuesday that there is no longer a substantial doubt about its ability to
continue as a "going concern." [ID:nN23106023]

The casino operator recently raised $2.6 billion from the sale of debt and
equity after warning in March that auditors would include the language in its
annual report.

Shares jumped 15.6 percent to $6.75 while fellow casino operator Las Vegas
Sands Corp (LVS.N) gained 9.1 percent to $8.04.

Reuters Messaging:rm://Charles.mikolajczak.reuters.com@reuters.net
1047 ET 24June2009-Osiris down after news on lung drug
------------------------------------------------------------------------------

Shares of Osiris Therapeutics Inc (OSIR.O) fell on Wednesday, a day after
the company's experimental adult stem cell treatment failed to improve lung
function in patients with chronic obstructive pulmonary disorder (COPD).

The drug didn't show a significant improvement in lung function as compared
to a dummy drug in a mid-stage trial with COPD patients. It is also currently
being tested in three late-stage studies in Crohns disease and graft versus
host disease.

For details, see [ID:nBNG271265]

Shares dropped 8 percent to $12.82.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net